Jon Nygaard is an attorney in the Palo Alto office of Wilson Sonsini Goodrich & Rosati. After serving as Special Counsel at the firm from 1998 to 2003, Jon returned in 2007 following three years as vice president and general counsel of the Endovascular Solutions division of Guidant Corporation. Prior to his earlier tenure at the firm, he was in the law department at Syntex Corporation for 14 years.

Bringing three decades of legal experience to the firm's drug and device regulatory and healthcare law practice within its life sciences practice, Jon provides assistance to clients in managing the regulatory aspects of developing and testing products, obtaining FDA approval or clearance to market them, complying with postmarketing requirements, and meeting the challenges of competitors in the marketplace.